melatonin has been researched along with Vitreoretinopathy, Proliferative in 2 studies
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)." | 7.73 | Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006) |
| "Melatonin is a known effective antitumour and anti-invasive agent, but whether it affects the formation and underlying mechanisms of PVR remains unclear." | 5.56 | Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy. ( Chen, PN; Chen, YS; Chien, HW; Chiou, HL; Hsieh, YH; Lee, CY; Lin, CL; Wang, K; Yang, SF, 2020) |
| "To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)." | 3.73 | Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006) |
| "Melatonin is a known effective antitumour and anti-invasive agent, but whether it affects the formation and underlying mechanisms of PVR remains unclear." | 1.56 | Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy. ( Chen, PN; Chen, YS; Chien, HW; Chiou, HL; Hsieh, YH; Lee, CY; Lin, CL; Wang, K; Yang, SF, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, SF | 1 |
| Chen, YS | 1 |
| Chien, HW | 1 |
| Wang, K | 1 |
| Lin, CL | 1 |
| Chiou, HL | 1 |
| Lee, CY | 1 |
| Chen, PN | 1 |
| Hsieh, YH | 1 |
| Er, H | 1 |
| Turkoz, Y | 1 |
| Mizrak, B | 1 |
| Parlakpinar, H | 1 |
2 other studies available for melatonin and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy.
Topics: Cathepsins; Cell Line; Cell Movement; Cell Proliferation; Epidermal Growth Factor; Gene Expression; | 2020 |
Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
Topics: Alkaloids; Animals; Benzophenanthridines; Disease Models, Animal; Disease Progression; Drug Therapy, | 2006 |